Zerigo Health
PrivateLast Round
Series B
Oct 21, 2021
Total Funding Raised
$70M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Zerigo Health operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in October 2021.
Zerigo Health is a healthcare technology company that develops handheld phototherapy medical devices and a smartphone application for the at-home treatment of chronic skin conditions such as psoriasis, eczema, and vitiligo.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zerigo Health Comparables
Compare Zerigo Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UVBioTek | 77% | |
| National Biological Corporation | 77% | |
| Cytokind, Inc. | 76% |
For institutional investors. Book with your work email.
Zerigo Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 21, 2021 | ||||
| Convertible Debt | Oct 31, 2019 | ||||
| Series A | Oct 23, 2019 | ||||
| Seed | Nov 21, 2016 | ||||
| Seed | Apr 7, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Zerigo Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series B, Series A |
| Leverage Health | Series B |
| 7wire Ventures | Series B, Series A |
| Cigna Ventures | Series B |
| Dragoneer Investment Group | Series B |
| HIG BioHealth Partners | Series A |
| General Catalyst | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 18, doubling the trailing average.
- Jul 27, 2026
Open roles increased to 13, 35% of headcount.
For institutional investors. Book with your work email.
Zerigo Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zerigo Health's valuation, stock price, and market status.
Is Zerigo Health a public or private company?
Zerigo Health is a private company.
What is the current stock price of Zerigo Health?
Zerigo Health is a private company, so its shares have no public market price. Caplight tracks Zerigo Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zerigo Health worth (valuation)?
Valuation information for Zerigo Health is not publicly available.
Can I buy Zerigo Health stock?
Zerigo Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zerigo Health's last funding round?
Zerigo Health's most recent funding round was Series B on October 21, 2021.
Who are the main investors in Zerigo Health?
Key investors in Zerigo Health include 7wire Ventures, HIG BioHealth Partners.
Will Zerigo Health IPO soon?
No public IPO plans have been announced for Zerigo Health.
How can I track Zerigo Health secondary market activity?
Caplight tracks bids, offers, and trades in Zerigo Health's shares on secondary markets.